Predictors of anti-reflux procedure failure in complex esophageal atresia patients.

ARP, Anti-reflux procedure ARPF, Anti-reflux procedure failure Abbreviations: EA, Esophageal atresia Anti-reflux procedure EGD, esophagogastric duodenoscopy Esophageal atresia GEJ, gastroesophageal junction HH, hiatal hernia Hiatal hernia LGEA, Long gap esophageal atresia MFOIS, Modified functional oral intake scale MIS, minimally invasive surgery Nissen fundoplication SSI, surgical sight infection UGI, upper gastrointestinal series gerd, Gastroesophageal reflux disease

Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 06 04 2021
revised: 02 08 2021
accepted: 09 08 2021
pubmed: 13 9 2021
medline: 16 6 2022
entrez: 12 9 2021
Statut: ppublish

Résumé

Anti-reflux procedures (ARP) in esophageal atresia (EA) patients can be challenging and prone to failure. These challenges become more evident with increasing complexity of EA. We sought to determine predictors of ARP failure in complex EA patients. Single-institution retrospective review of complex EA patients (e.g. long-gap EA, esophageal strictures, hiatal hernia, and reoperative ARP) who underwent an ARP from 2002 to 2019. ARP failure was defined as hiatal hernia recurrence, wrap migration/loosening, or need for reoperation. Predictors of failure were evaluated using univariate and multivariable time-to-event analysis. 121 patients underwent 140 ARP at a median age of 13.5 months (IQR 7, 26.5). Nissen fundoplication (89%) was the most common ARP. Mesh (bovine pericardium) reinforcement was used in 41% of the patients. Median follow-up was 3.2 years (IQR 0.9, 5.8); 44 instances of ARP failure occurred (31%), though only 20 (14%) required reoperation. Median time to failure was 8.7 months (IQR 3.2, 25). Though fewer mesh-reinforced ARP failed (21% with vs 39% without, p = 0.02), on multivariable analysis only partial fundoplication (aHR 2.22 [95% CI 1.01-4.78]) and minimally invasive repair (aHR 2.57 [95% CI 1.12-6.01]) were significant predictors of ARP failure. In our practice of complex EA patients, where ARP fail in nearly one third of cases, a Nissen fundoplication performed via laparotomy provided the lowest risk of ARP failure.

Sections du résumé

BACKGROUND BACKGROUND
Anti-reflux procedures (ARP) in esophageal atresia (EA) patients can be challenging and prone to failure. These challenges become more evident with increasing complexity of EA. We sought to determine predictors of ARP failure in complex EA patients.
METHODS METHODS
Single-institution retrospective review of complex EA patients (e.g. long-gap EA, esophageal strictures, hiatal hernia, and reoperative ARP) who underwent an ARP from 2002 to 2019. ARP failure was defined as hiatal hernia recurrence, wrap migration/loosening, or need for reoperation. Predictors of failure were evaluated using univariate and multivariable time-to-event analysis.
RESULTS RESULTS
121 patients underwent 140 ARP at a median age of 13.5 months (IQR 7, 26.5). Nissen fundoplication (89%) was the most common ARP. Mesh (bovine pericardium) reinforcement was used in 41% of the patients. Median follow-up was 3.2 years (IQR 0.9, 5.8); 44 instances of ARP failure occurred (31%), though only 20 (14%) required reoperation. Median time to failure was 8.7 months (IQR 3.2, 25). Though fewer mesh-reinforced ARP failed (21% with vs 39% without, p = 0.02), on multivariable analysis only partial fundoplication (aHR 2.22 [95% CI 1.01-4.78]) and minimally invasive repair (aHR 2.57 [95% CI 1.12-6.01]) were significant predictors of ARP failure.
CONCLUSION CONCLUSIONS
In our practice of complex EA patients, where ARP fail in nearly one third of cases, a Nissen fundoplication performed via laparotomy provided the lowest risk of ARP failure.

Identifiants

pubmed: 34509283
pii: S0022-3468(21)00546-7
doi: 10.1016/j.jpedsurg.2021.08.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1321-1330

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Kyle Thompson (K)

Department of General Surgery, Boston Children's Hospital, Boston, MA USA.

Benjamin Zendejas (B)

Department of General Surgery, Boston Children's Hospital, Boston, MA USA.

Ali Kamran (A)

Department of General Surgery, Boston Children's Hospital, Boston, MA USA.

Wendy Jo Svetanoff (WJ)

Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, MO USA.

Jay Meisner (J)

Department of General Surgery, Boston Children's Hospital, Boston, MA USA.

David Zurakowski (D)

Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA USA.

Steven J Staffa (SJ)

Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA USA.

Peter Ngo (P)

Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA USA.

Michael Manfredi (M)

Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA USA.

Jessica L Yasuda (JL)

Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA USA.

Russell W Jennings (RW)

Department of General Surgery, Boston Children's Hospital, Boston, MA USA.

C Jason Smithers (CJ)

Department of General Surgery, Boston Children's Hospital, Boston, MA USA; Department of Surgery, Johns Hopkins All Children's Hospital, St. Petersburg, FL USA. Electronic address: Thomas.Hamilton@childrens.harvard.edu.

Thomas E Hamilton (TE)

Department of General Surgery, Boston Children's Hospital, Boston, MA USA. Electronic address: thomas.hamilton@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH